Chronic Pancreatitis Clinical Research Consortium at Stanford
Official title: The Stanford Clinical Center for the Chronic Pancreatitis Research Consortium (CPCRC)
Funded at Stanford University · NIH-11400526 · Data updated 2026-11-12
A Stanford-based effort is renewing a patient-centered program to study chronic pancreatitis and recurrent acute pancreatitis, with ongoing recruitment of both adult and pediatric participants.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Stanford University NIH-funded |
| Lab location | 1 site (Stanford, United States) |
| Project start | September 28, 2015 |
| Project end | June 30, 2030 |
| Funding year | 2026 |
| Award (this year) | $505,414 |
| NIH project number | 5U01DK108300-12 |
| Project ID | NIH-11400526 on NIH RePORTER |
Who could benefit from this research
✓Could help
Adults with chronic or recurrent acute pancreatitis and children enrolled in INSPPIRE2 who meet study criteria.
✕Less likely to help
People outside the pancreatitis spectrum or those not meeting study criteria may not benefit.
What this research studies
This grant supports two joined studies under the Chronic Pancreatitis Clinical Research Consortium: PROCEED, which follows adults with chronic pancreatitis to learn about disease progression, and INSPPIRE2, a pediatric cohort tracking children with the condition. Researchers will collect clinical data and prospectively obtained specimens to explore how the immune system relates to disease activity and outcomes. The Stanford team has demonstrated success in enrolling and retaining participants and will continue collaboration with experts in endocrinology, radiology, and immunology. The work aims to translate immune findings into better diagnosis and management of pancreatitis. Participants may contribute blood or tissue samples and provide information through regular follow-up visits.
Why it matters
Potential benefit: New insights into immune mechanisms could lead to better diagnosis, prognosis, and treatment options for pancreatitis.
How similar studies have gone: Prior efforts showed immune signaling pathways can aid diagnosis; ongoing work seeks to validate and extend these findings.
Where this research is happening
-
Stanford University
Stanford, United States Active
Researchers
- Principal investigator: Park, Walter Gwang-Up — Stanford University
- Study coordinator: Park, Walter Gwang-Up
Related research
Other NIH-funded projects on the same topics.
-
Chronic Pancreatitis and Related Conditions Data Center Supports Multi-Center Research
A national effort to organize and share clinical data and biosamples from people with chronic pancreatitis, pancreatogenic diabetes, and pancreatic cancer to speed biomarker discovery and new treatments.
-
Malabsorption Blood Test for Exocrine Pancreatic Function in Chronic Pancreatitis
A blood test (MBT) will help identify people with mild to moderate pancreatic fat malabsorption and show how well enzyme therapy improves their quality of life.
-
Chronic Pancreatitis Clinical Research Cohort and Biorepository
A long-term study at UF/Advent Health following adults with acute, relapsing, and chronic pancreatitis to build a detailed group with biospecimens and data for better diagnosis and personalized care.
-
Cedars-Sinai Center leads research on chronic pancreatitis and pancreatic cancer
A Cedars-Sinai research center is renewing its program to study chronic pancreatitis, diabetes-related pancreatic disease, and pancreatic cancer so doctors can better understand and treat these conditions.
-
UPMC Center for Pancreatitis and Diabetes research program
A specialized center at the University of Pittsburgh is advancing clinical and biological studies of chronic pancreatitis, recurrent acute pancreatitis, and diabetes to improve understanding and care.
-
Chronic Pancreatitis Research Network to Understand Symptoms and Find Treatments
This project advances studies of chronic pancreatitis to understand why some people progress and to test new ideas that could diagnose or slow the disease.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.